CORDIS
EU research results

CORDIS

English EN

Tobacco cessation within TB programmes: A ‘real world’ solution for countries with dual burden of disease

Project information

Grant agreement ID: 680995

Status

Closed project

  • Start date

    1 November 2015

  • End date

    31 October 2019

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 2 999 828,75

  • EU contribution

    € 2 999 828,75

Coordinated by:

UNIVERSITY OF YORK

United Kingdom

Objective

We aim to reduce the burden of tobacco-related lung diseases. Our approach is to integrate inexpensive tobacco cessation strategies of proven efficacy into TB control programmes. This has three advantages: a) Preventing non-communicable diseases as well as reducing TB-related deaths; b) TB patients are more likely to quit tobacco than healthy smokers – ‘teachable moments’; and c) in the absence of specialist infrastructure, an approach to ‘piggyback’ cessation on existing programmes is a desirable policy imperative.
We will first assess the effectiveness and cost-effectiveness of tobacco cessation strategies in helping TB patients to quit and improving their TB outcomes - the effectiveness goal; and then explore how best these strategies can be delivered, sustained and scaled-up – the implementation goal. We propose six work packages for Bangladesh, Nepal and Pakistan - high TB and tobacco burden countries.
WP1 Development & Feasibility: To optimise the delivery of tobacco cessation strategies within TB programmes (focus group discussions [FGD], interviews, surveys, expert panel workshops)
WP2 & 3 Effect and economic evaluation: To assess the effectiveness and cost effectiveness of cytisine with behavioural support vs. behavioural support alone on tobacco cessation and TB outcomes (randomised controlled trial [RCT])
WP4 Process evaluation: To study the design and delivery of the tobacco cessation strategies (FGD, observations, exit interviews)
WP5 Context evaluation: To study the influence of contextual factors on the RCT outcomes (lit. review, interviews, surveys, analysis)
WP6 Scale up & Sustainability: To assess sustainability of the cessation strategies and identify the likely costs, obstacles and opportunities for scaling these up (FGD, interviews, cost and outcomes analysis)
Our ambition is that by studying the ‘real world’ influences on the implementation and success of tobacco cessation we will be able to translate our findings into benefits for patients

Coordinator

UNIVERSITY OF YORK

Address

Heslington
Yo10 5dd York North Yorkshire

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 085 001,25

Participants (9)

ARK FOUNDATION

Bangladesh

EU Contribution

€ 477 773,75

HEALTH RESEARCH AND SOCIAL DEVELOPMENT FORUM

Nepal

MINISTRY OF NATIONAL HEALTH SERICES, REGULATION AND COORDINATION

Pakistan

EU Contribution

€ 113 925

THE INITIATIVE

Pakistan

EU Contribution

€ 430 743,75

HEINRICH-HEINE-UNIVERSITAET DUESSELDORF

Germany

EU Contribution

€ 209 845

THE UNIVERSITY OF EDINBURGH

United Kingdom

EU Contribution

€ 60 096,25

UNIVERSITY OF LEEDS

United Kingdom

EU Contribution

€ 357 205

VSEOBECNA FAKULTNI NEMOCNICE V PRAZE

Czechia

EU Contribution

€ 140 141,25

HERD INTERNATIONAL PVT LTD

Nepal

EU Contribution

€ 125 097,50

Project information

Grant agreement ID: 680995

Status

Closed project

  • Start date

    1 November 2015

  • End date

    31 October 2019

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 2 999 828,75

  • EU contribution

    € 2 999 828,75

Coordinated by:

UNIVERSITY OF YORK

United Kingdom